Bicycle Therapeutics Ipo Nasdaq. Die bicycle therapeutics limited spons. The company reported 0 67 earnings per share eps for the quarter missing the zacks consensus estimate of 0 48 by 0 19.
Bicycle priced its offering of approximately 4 4 million shares at 14 apiece which was the low end of its targeted price range. Bicycle therapeutics plc american depositary shares bcyc stock quotes nasdaq offers stock quotes market activity data for us and global markets. Bicycle therapeutics had a negative return.
Cambridge england boston business wire may 22 2019 bicycle therapeutics plc nasdaq.
Bicycle therapeutics plc american depositary shares bcyc stock quotes nasdaq offers stock quotes market activity data for us and global markets. The company had revenue of 1 57 million for the quarter compared to the consensus estimate of 2 11 million. Bicycles are fully synthetic short peptides constrained to form two loops that stabilize their structural geometry. Bicycle therapeutics plc american depositary shares bcyc stock quotes nasdaq offers stock quotes market activity data for us and global markets.